Gamma Knife and RapidArc Radiosurgery Equally Effective
By MedImaging International staff writers Posted on 08 Mar 2016 |
Image: The RapidArc Radiosurgery system (Photo courtesy of Varian Medical Systems).
A new study comparing Gamma Knife and RapidArc radiosurgery found that while each system offers a different strength, they are equally effective at eradicating cancer in the brain.
Researchers at Thomas Jefferson University (TJU; Philadelphia, PA, USA) conducted a study involving six patients with three or four small brain metastases that varied from 0.1–10.5 cm3 in size. Stereotactic radiosurgery (SRS) modalities for multiple brain metastases were made using both the Gamma Knife (GK) Perfexion system and a single-isocenter, multiple non-coplanar RapidArc device, as determined according to the size of the target.
The results showed that the Gamma Knife system was slightly more effective than RapidArc at focusing the beam of radiation at a very low-dose (<3 Gy), thus limiting spread to normal tissue. On the other hand, the RapidArc system offered much quicker treatment; compared to GK treatment, which typically takes 60–100 minutes, RapidArc was about 3-5 times faster. The study was published on January 25, 2016, in Frontiers in Oncology.
“Understanding the benefits of advanced radiosurgery technology is essential because there has been, and will continue to be, an increase in cases of brain metastases,” said study coauthor Adam Dicker, MD, PhD, of the TJU Sidney Kimmel Medical College. “Chemotherapies and targeted agents can't reach the brain and the central nervous system because of the blood-brain barrier. The results are that a number of different cancers are now showing up in the brain.”
The Gamma Knife, a product of Elekta (Stockholm, Sweden), features a circular array of 201 beams of gamma radiation that meet at a single point. The downside of the treatment, although very accurate, is that patients need to be protected with a helmet. The RapidArc Radiosurgery system, a product of Varian Medical Systems (Palo Alto, CA, USA), emits very small, high-energy X-ray photons with varying intensities aimed at a tumor and then rotated around the patient, resulting in complete three-dimensional (3D) dose delivery at a rate at least three times faster than GK. Advantages include the ability to treat multiple metastases simultaneously, rather than sequentially, and frameless immobilization.
Related Links:
Thomas Jefferson University
Elekta
Varian Medical Systems
Researchers at Thomas Jefferson University (TJU; Philadelphia, PA, USA) conducted a study involving six patients with three or four small brain metastases that varied from 0.1–10.5 cm3 in size. Stereotactic radiosurgery (SRS) modalities for multiple brain metastases were made using both the Gamma Knife (GK) Perfexion system and a single-isocenter, multiple non-coplanar RapidArc device, as determined according to the size of the target.
The results showed that the Gamma Knife system was slightly more effective than RapidArc at focusing the beam of radiation at a very low-dose (<3 Gy), thus limiting spread to normal tissue. On the other hand, the RapidArc system offered much quicker treatment; compared to GK treatment, which typically takes 60–100 minutes, RapidArc was about 3-5 times faster. The study was published on January 25, 2016, in Frontiers in Oncology.
“Understanding the benefits of advanced radiosurgery technology is essential because there has been, and will continue to be, an increase in cases of brain metastases,” said study coauthor Adam Dicker, MD, PhD, of the TJU Sidney Kimmel Medical College. “Chemotherapies and targeted agents can't reach the brain and the central nervous system because of the blood-brain barrier. The results are that a number of different cancers are now showing up in the brain.”
The Gamma Knife, a product of Elekta (Stockholm, Sweden), features a circular array of 201 beams of gamma radiation that meet at a single point. The downside of the treatment, although very accurate, is that patients need to be protected with a helmet. The RapidArc Radiosurgery system, a product of Varian Medical Systems (Palo Alto, CA, USA), emits very small, high-energy X-ray photons with varying intensities aimed at a tumor and then rotated around the patient, resulting in complete three-dimensional (3D) dose delivery at a rate at least three times faster than GK. Advantages include the ability to treat multiple metastases simultaneously, rather than sequentially, and frameless immobilization.
Related Links:
Thomas Jefferson University
Elekta
Varian Medical Systems
Latest Nuclear Medicine News
- New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy
- New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment